Addition of Rituximab to High-Dose Methotrexate Regimens Improves Complete Response Rates and Median Overall Survival in Non-Germinal Center Primary CNS LymphomaNeelam Mistry,Derek E. Smith,Manali Kamdar,Bradley M. Haverkos,Douglas NeyBlood（2018）引用 0|浏览13AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
